Entrada Therapeutics, Inc. (TRDA) › Shareholders' EquityEntrada Therapeutics, Inc. (TRDA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$15.52M2020: -$41.49M2021: $298.72M2022: $212.55M2023: $242.36M2024: $428.68M2025: $306.13M$306.13M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$306.13M-28.6%2024$428.68M+76.9%2023$242.36M+14.0%2022$212.55M-28.8%2021$298.72M+820.0%2020-$41.49M-167.4%2019-$15.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share